{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T04:25:31Z","timestamp":1785299131146,"version":"3.55.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.oret.2022.12.009","type":"journal-article","created":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T05:57:56Z","timestamp":1671775076000},"page":"480-488","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["A Comparison of Ocular Complications after 0.7 mg Dexamethasone Implant versus 2 mg of Intravitreal Triamcinolone in Vitrectomized Eyes"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2640-6079","authenticated-orcid":false,"given":"Taku","family":"Wakabayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine K.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah E.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raziyeh","family":"Mahmoudzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2322-5782","authenticated-orcid":false,"given":"Michael K.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirataollah","family":"Salabati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunir J.","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc J.","family":"Spirn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2022.12.009_bib1","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0161-6420(80)35114-2","article-title":"Cystoid macular edema after retinal detachment surgery","volume":"87","author":"Meredith","year":"1980","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2022.12.009_bib2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0002-9394(14)73255-6","article-title":"Macular changes after retinal detachment surgery","volume":"108","author":"Sabates","year":"1989","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2022.12.009_bib3","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1097\/IAE.0000000000001627","article-title":"Residual intraretinal edema after 25-gauge vitrectomy and macular pucker removal: is intraoperative sustained\u2013released dexamethasone a real treatment option?","volume":"38","author":"Guidi","year":"2018","journal-title":"Retin"},{"key":"10.1016\/j.oret.2022.12.009_bib4","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.ophtha.2009.02.008","article-title":"Incidence of postvitrectomy macular edema using optical coherence tomography","volume":"116","author":"Kim","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2022.12.009_bib5","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.2147\/OPTH.S304030","article-title":"One-year outcome of aflibercept intravitreal injection in vitrectomized eyes with diabetic macular edema","volume":"15","author":"Tran","year":"2021","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.oret.2022.12.009_bib6","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ajo.2007.02.048","article-title":"Bevacizumab (Avastin) for diabetic macular edema in previously vitrectomized eyes","volume":"144","author":"Yanyali","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2022.12.009_bib7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3928\/23258160-20121221-09","article-title":"Comparative effectiveness of the dexamethasone intravitreal implant in vitrectomized and non-vitrectomized eyes with macular edema secondary to central retinal vein occlusion","volume":"44","author":"Shaikh","year":"2013","journal-title":"Ophthalmic Surg Lasers Imaging Retin"},{"key":"10.1016\/j.oret.2022.12.009_bib8","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1089\/jop.2018.0012","article-title":"Efficacy of multiple dexamethasone intravitreal implants for refractory retinal vein occlusion-related macular edema and effect of prior vitrectomy","volume":"34","author":"Houben","year":"2018","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.oret.2022.12.009_bib9","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000455280","article-title":"Postsurgical cystoid macular edema","volume":"58","author":"Zur","year":"2017","journal-title":"Dev Ophthalmol"},{"key":"10.1016\/j.oret.2022.12.009_bib10","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/IAE.0b013e318206d18c","article-title":"Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients","volume":"31","author":"Boyer","year":"2011","journal-title":"Retin"},{"key":"10.1016\/j.oret.2022.12.009_bib11","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1097\/IAE.0000000000000105","article-title":"Intravitreal dexamethasone implant for refractory macular edema secondary to vitrectomy for macular pucker","volume":"34","author":"Furino","year":"2014","journal-title":"Retin"},{"key":"10.1016\/j.oret.2022.12.009_bib12","doi-asserted-by":"crossref","first-page":"485","DOI":"10.5301\/ejo.5000768","article-title":"Efficacy and safety of postvitrectomy intravitreal triamcinolone therapy for diabetic macular edema","volume":"26","author":"Costa","year":"2016","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.oret.2022.12.009_bib13","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/00006982-200507000-00002","article-title":"Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and nonvitrectomized eyes","volume":"25","author":"Chin","year":"2005","journal-title":"Retina"},{"key":"10.1016\/j.oret.2022.12.009_bib14","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0161-6420(02)01969-3","article-title":"Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection","volume":"110","author":"Beer","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2022.12.009_bib15","article-title":"Comparison of the effect of intravitreal dexamethasone implant in vitrectomized and nonvitrectomized eyes for the treatment of diabetic macular edema","volume":"2018","author":"\u00c7evik","year":"2018","journal-title":"J\u00a0Ophthalmol"},{"key":"10.1016\/j.oret.2022.12.009_bib16","article-title":"Twelve-month follow-up of dexamethasone implants for macular edema from various diseases in vitrectomized and nonvitrectomized eyes","volume":"2016","author":"Novais","year":"2016","journal-title":"J\u00a0Ophthalmol"},{"key":"10.1016\/j.oret.2022.12.009_bib17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1089\/jop.2015.0045","article-title":"Efficacy of intravitreal triamcinolone acetonide for diabetic macular edema after vitrectomy","volume":"32","author":"Watanabe","year":"2016","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.oret.2022.12.009_bib18","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/ICU.0b013e328338679a","article-title":"Complications of intravitreal injections","volume":"21","author":"Sampat","year":"2010","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.oret.2022.12.009_bib19","first-page":"1","article-title":"Common and rare ocular side-effects of the dexamethasone implant","volume":"25","author":"Adeniran","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.oret.2022.12.009_bib20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.survophthal.2007.12.005","article-title":"Intravitreal steroids for macular edema: the past, the present, and the future","volume":"53","author":"Cunningham","year":"2008","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.oret.2022.12.009_bib21","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1167\/iovs.13-12008","article-title":"Influence of incisional vitreous incarceration in sclerotomy closure competency after transconjunctival sutureless vitrectomy","volume":"54","author":"Benitez-Herreros","year":"2013","journal-title":"Investig Opthalmol Vis Sci"},{"key":"10.1016\/j.oret.2022.12.009_bib22","first-page":"103","article-title":"Rate of hypotony and intraocular pressure fluctuation immediately after intravitreal dexamethasone implantation in vitrectomized eyes","volume":"43","author":"Alag\u00f6z","year":"2020","journal-title":"J\u00a0Fr Ophthalmol"},{"key":"10.1016\/j.oret.2022.12.009_bib23","doi-asserted-by":"crossref","first-page":"341","DOI":"10.5301\/ejo.5001059","article-title":"Cauterization of Ozurdex wound for the prevention of scleral leakage in vitrectomized eyes","volume":"28","author":"Furino","year":"2018","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.oret.2022.12.009_bib24","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jcjo.2020.06.021","article-title":"Ocular hypertension following 40 mg sub-Tenon triamcinolone versus 0.7 mg dexamethasone implant versus 2 mg intravitreal triamcinolone","volume":"55","author":"Kuley","year":"2020","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.oret.2022.12.009_bib25","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.ophtha.2010.03.032","article-title":"Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion","volume":"117","author":"Haller","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2022.12.009_bib26","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/IAE.0b013e318297f842","article-title":"Efficacy and safety of two or more dexamethasone intravitreal implant injections for treatment of macular edema related to retinal vein occlusion (shasta study)","volume":"34","author":"Capone","year":"2014","journal-title":"Retina"},{"key":"10.1016\/j.oret.2022.12.009_bib27","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1089\/jop.2010.0039","article-title":"Secondary ocular hypertension after intravitreal injection with 2 mg or 4 mg of triamcinolone in retinal vein occlusion","volume":"26","author":"Chuang","year":"2010","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.oret.2022.12.009_bib28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/08820538.2020.1758161","article-title":"Ocular hypertension following intravitreal injection of 0.7 mg dexamethasone implant versus 2 mg triamcinolone","volume":"35","author":"Kuley","year":"2020","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.oret.2022.12.009_bib29","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1097\/IAE.0000000000001883","article-title":"Intraocular dexamethasone implant position in situ and ocular hypertension","volume":"38","author":"Sudhalkar","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.oret.2022.12.009_bib30","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/eye.2015.73","article-title":"Long-term evaluation of dexamethasone intravitreal implant in vitrectomized and non-vitrectomized eyes with macular edema secondary to non-infectious uveitis","volume":"29","author":"Pelegr\u00edn","year":"2015","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.oret.2022.12.009_bib31","article-title":"Comparison of the intraocular pressure following an intravitreal triamcinolone acetonide injection for diabetic macula oedema in vitrectomised and non-vitrectomised eyes","volume":"6","author":"Orii","year":"2021","journal-title":"BMJ Open Ophthalmol"},{"key":"10.1016\/j.oret.2022.12.009_bib32","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000496705","article-title":"Treatment of\u00a0macular edema after pars plana vitrectomy for idiopathic epiretinal membrane using intravitreal dexamethasone implant: long-term outcomes","volume":"242","author":"Chatziralli","year":"2019","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.oret.2022.12.009_bib33","article-title":"Evaluation of functional outcomes and OCT-biomarkers after intravitreal dexamethasone implant for postoperative cystoid macular edema in vitrectomized eyes","volume":"2020","author":"Freissinger","year":"2020","journal-title":"J\u00a0Ophthalmol"},{"key":"10.1016\/j.oret.2022.12.009_bib34","article-title":"Dexamethasone intravitreal implant (Ozurdex) for long-term macular edema after epiretinal membrane peeling surgery","volume":"2018","author":"Chang","year":"2018","journal-title":"J\u00a0Ophthalmol"},{"key":"10.1016\/j.oret.2022.12.009_bib35","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/IAE.0b013e31827e247b","article-title":"Dexamethasone intravitreal implant for treatment of uveitic persistent cystoid macular edema in vitrectomized patients","volume":"33","author":"Ad\u00e1n","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.oret.2022.12.009_bib36","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/IAE.0000000000003380","article-title":"Clinical features of intravitreal dexamethasone implantation in vitrectomized eyes of patients with diabetic macular edema","volume":"42","author":"Kwon","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.oret.2022.12.009_bib37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40942-018-0114-2","article-title":"Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety","volume":"4","author":"Mishra","year":"2018","journal-title":"Int J Retina Vitreous"},{"key":"10.1016\/j.oret.2022.12.009_bib38","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1097\/IAE.0000000000000475","article-title":"The OMAR study: comparison of Ozurdex and triamcinolone acetonide for refractory cystoid macular edema in retinal vein occlusion","volume":"35","author":"Ozkok","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.oret.2022.12.009_bib39","doi-asserted-by":"crossref","first-page":"280","DOI":"10.4103\/tjo.tjo_87_17","article-title":"Persistent vitreous hemorrhage after intravitreal injection of dexamethasone intravitreal implant in patients with diabetic macular edema","volume":"9","author":"Li","year":"2019","journal-title":"Taiwan J Ophthalmol"},{"key":"10.1016\/j.oret.2022.12.009_bib40","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/IAE.0000000000002475","article-title":"Intravitreal dexamethasone implant migration into the anterior chamber: a multicenter study from the pan-American collaborative retina study group","volume":"40","author":"Gon\u00e7alves","year":"2020","journal-title":"Retina"},{"key":"10.1016\/j.oret.2022.12.009_bib41","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12886-019-1122-1","article-title":"Risk factors for and management of anterior chamber intravitreal dexamethasone implant migration","volume":"19","author":"R\u00f6ck","year":"2019","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.oret.2022.12.009_bib42","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1007\/s00417-017-3705-y","article-title":"The clinical outcomes of surgical management of anterior chamber migration of a dexamethasone implant (Ozurdex\u00ae)","volume":"255","author":"Kang","year":"2017","journal-title":"Graefe Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2022.12.009_bib43","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ophtha.2013.06.033","article-title":"Dexamethasone implant anterior chamber migration risk factors, complications, and management strategies","volume":"121","author":"Khurana","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2022.12.009_bib44","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/ICU.0000000000000365","article-title":"Anterior segment migration of dexamethasone implant: risk factors, complications, and management","volume":"28","author":"Rahimy","year":"2017","journal-title":"Curr Opin Ophthalmol"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653022006248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653022006248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:31:46Z","timestamp":1762853506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653022006248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S2468653022006248"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2022.12.009","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Comparison of Ocular Complications after 0.7 mg Dexamethasone Implant versus 2 mg of Intravitreal Triamcinolone in Vitrectomized Eyes","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2022.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}